Bank of Montreal
TMCI icon

Bank of Montreal’s Treace Medical Concepts TMCI Stock Holding History

Bank of Montreal’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,373
Closed -$54.6K – 4280
2022
Q3 		$54 Buy
2,373
+2,347
+9,027% +$45.4K ﹤0.01% 3621
2022
Q2 		$0 Buy
+26
New +$438 ﹤0.01% 4453

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bank of Montreal's TMCI Position: Q4 2022 in Review

Bank of Montreal sold out of Treace Medical Concepts (TMCI) in Q4 2022, closing a stake of 2,373 shares — an estimated $54.6K sold.

Bank of Montreal first reported a position in TMCI in Q2 2022 and held it in 2 quarters. The position peaked at $54 in Q3 2022. 106 funds tracked by Wall St. Rank hold TMCI as of Q4 2022.

  • Bank of Montreal reported no remaining Treace Medical Concepts position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 2,373 Treace Medical Concepts shares in Q4 2022, an estimated $54.6K.
  • Bank of Montreal first reported a position in Treace Medical Concepts in Q2 2022 and held it in 2 quarters.
  • Bank of Montreal's Treace Medical Concepts position peaked at $54 in Q3 2022.
  • 106 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.